Czechia· CZ-0253321

HEVASCOL

A ethylester von iodierten fettsäuren product containing ethiodized oil, registered in Czechia by Guerbet, Roissy CdG Cedex. The same ATC class is registered in 9 of our 19 countries.

ATC V08AD01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedHEVASCOLATCV08AD01REGISTER NO.CZ-0253321PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Ethylester von iodierten fettsäuren is registered in 9 of 19 countries.

Countries holding a registration under ATC V08AD01 (ethylester von iodierten fettsäuren), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 6 of them publish a price we can compare per daily dose

Ethylester von iodierten fettsäuren · ATC V08AD01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
ETHIODIZED OIL
Manufacturer
Guerbet, Roissy CdG Cedex
Country
Czechia (CZ)
ATC code
V08AD01
ATC class
Ethylester von iodierten Fettsäuren
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for ethylester von iodierten fettsäuren.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ethylester von iodierten fettsäuren · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • AldesleukinL03AC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ethylester von iodierten fettsäuren in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethylester von iodierten fettsäuren products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Cyprus · Hevascol
  • Germany · Lipiodol Ultra-Fluid
  • Spain · Hevascol
  • Italy · Hevascol
  • Slovakia · Lodiolip

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8de6277a-e745-40d3-b41e-5db73686cfb1
GET /v1/drugs/8de6277a-e745-40d3-b41e-5db73686cfb1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ SOL",
  "source": "sukl",
  "strength": "480MG I/ML",
  "pack_size": "1X10ML",
  "substance": "ETHIODIZED OIL",
  "cz_kod_sukl": "0253321",
  "product_type": "CH",
  "substance_codes": "1776",
  "registration_state": "R",
  "registration_number": "48/039/21-C"
}

See everything about ethylester von iodierten fettsäuren.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.